These results suggest that JOA could decrease the colony formation of CML cells regardless of BCR-ABL mutational forms, which was due to the promotion of cell differentiation by JOA. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.